The collecting duct (CD) is a major renal site for the hormonal regulation of Na homeostasis and is critical for systemic arterial blood pressure control. Our previous studies demonstrated that the endothelin-1 gene (edn1) is an early response gene to the action of aldosterone. Because aldosterone and endothelin-1 (ET-1) have opposing actions on Na reabsorption (JNa) in the kidney, we postulated that stimulation of ET-1 by aldosterone acts as a negative feedback mechanism, acting locally within the CD. Aldosterone is known to increase JNa in the CD, in part, by stimulating the epithelial Na channel (ENaC). In contrast, ET-1 increases Na and water excretion through its binding to receptors in the CD. To date, direct measurement of the quantitative effect of ET-1 on transepithelial JNa in the isolated in vitro microperfused mouse CD has not been determined. We observed that the CD exhibits substantial JNa in male and female mice that is regulated, in part, by a benzamil-sensitive pathway, presumably ENaC. ENaCmediated JNa is greater in the cortical CD (CCD) than in the outer medullary CD (OMCD); however, benzamil-insensitive JNa is present in the CCD and not in the OMCD. In the presence of ET-1, ENaCmediated JNa is significantly inhibited. Blockade of either ETA or ETB receptor restored JNa to control rates; however, only ETA receptor blockade restored a benzamil-sensitive component of JNa. We conclude 1) Na reabsorption is mediated by ENaC in the CCD and OMCD and also by an ENaC-independent mechanism in the CCD; and 2) ET-1 inhibits JNa in the CCD through both ETA and ETB receptor-mediated pathways. sodium reabsorption; kidney; mineralocorticoid; collecting duct; endothelin-1; aldosterone THE CORTICOSTEROID HORMONE aldosterone stimulates sodium (Na) reabsorption in the collecting duct (CD) via the concerted action of a luminal membrane benzamil-sensitive epithelial Na channel (ENaC) and a basolateral Na-K-ATPase. Endothelin-1 (ET-1) production is stimulated by aldosterone and glucocorticoid in the CD (10, 25, 26) and is an important regulator of systemic blood pressure and volume homeostasis. See Kohan et al. (13) for review.
THE CORTICOSTEROID HORMONE aldosterone stimulates sodium (Na) reabsorption in the collecting duct (CD) via the concerted action of a luminal membrane benzamil-sensitive epithelial Na channel (ENaC) and a basolateral Na-K-ATPase. Endothelin-1 (ET-1) production is stimulated by aldosterone and glucocorticoid in the CD (10, 25, 26) and is an important regulator of systemic blood pressure and volume homeostasis. See Kohan et al. (13) for review.
ET-1 mediates its actions by binding to ET A and ET B receptors, although the relative expression and localization of these receptors in the CD are still under investigation. The ET B receptor binds ET-1, ET-2, and ET-3 with similar affinity; however, the ET A receptor has the greatest affinity for ET-1.
ET B expression in the CD has been clearly demonstrated with the greatest levels in the inner medullary CD (IMCD) where it mediates antihypertensive effects. ET A expression has been reported by immunohistochemistry in the rat distal tubule and cortical CD (CCD) with faint staining in the IMCD (32) , in the rat CD (21) , and in the basal infoldings of the rat CD with the strongest staining in the IMCD (33) . In binding assay experiments, ET A receptors were found in the rat and rabbit IMCD (6) .
CD principal cell-specific knockout (KO) of either ET-1 (CD ET-1 KO) or the ET B receptor (CD ET B KO) in mice caused a significant increase in blood pressure that was greater on a high-salt diet, whereas CD ET A receptor KO (CD ET A KO) mice were normotensive. Of note, the blood pressures of the CD ET-1 KO were greater than those of the CD ET B KO. However, the combined KO of both ET receptors (CD ET A/B KO) had blood pressures similar to the CD ET-1 KO but greater than those of the CD ET B KO, suggesting that ET A and ET B may have a combined hypotensive effect (9) . In fact, renal medullary infusion of ET-1 in ET B receptor-deficient female rats caused Na excretion that could be blocked by ET A receptor antagonism (19) . Recent in vivo studies on the role of ET A receptors in mediating the effects of ET-1 in the renal medulla are reviewed in Nakano and Pollock (18) . ET receptors can form homo-and heterodimers that have different functional and pharmacological profiles (1) , which reflects the complexity of the role of the ET-1 receptors in blood pressure regulation.
ET-1 inhibited Na-K-ATPase activity in isolated rabbit IMCD cells (34) , AVP-stimulated chloride and fluid absorption in the CCD of deoxycorticosterone-treated rats (29) , and ENaC activity in split-open rat and mouse CCD (2, 3) . The effect of ET-1 directly on Na transport has not been measured at the level of the isolated, microperfused CD. The purpose of this study was to definitively test the effects of ET-1 on ENaCmediated (benzamil-sensitive) Na transport by directly measuring lumen-to-bath isotopic 22 Na reabsorption (J Na ) using in vitro microperfusion. First, we characterize ENaC-mediated J Na in the CCD and OMCD and confirmed that the CCD also has the capacity to reabsorb Na through a benzamil-insensitive pathway. We observed that ET-1 decreased Na reabsorption in the CCD, and we evaluated the role of ET-1 receptors in mediating this response. The current findings are consistent with a model of ET-1 downregulation of Na reabsorption through mechanisms involving both ET receptors.
METHODS

Animals.
All animal use was in compliance with the American Physiological Society's Guiding Principles in the Care and Use of Laboratory Animals, and animal use protocols were approved by the North Florida/South Georgia Veterans Administration Institutional Animal Care and Use Committee. Wild-type (WT; C57BL/6J) mice between 8 and 23 wk (mean age 13.8 Ϯ 0.4) were fed a normal laboratory chow containing 0.2% Na, 0.5% K (Teklad 2018, Madison, WI) and allowed free access to water. Mice were euthanized by intraperitoneal injection of Na-pentobarbital (120 mg/kg) and cervical dislocation.
CD isolation and in vitro microperfusion. Standard techniques (4, 35) with the following modifications were used. The dissection, luminal perfusion, and bath solution were (in mM) 100 NaCl, 5 KCl, 25 NaHCO 3, 1.5 Na2HPO4, 10 NaCH3CO2, 1.0 MgCl2, 8 glucose, 5 alanine, 1.2 CaCl2, and 1.5 mannitol gassed with 95% O2-5% CO2 to pH 7.4. Both kidneys were quickly removed, and ϳ1-mm coronal slices were placed in a chilled Petri dish containing the dissection solution. A single CD segment was hand dissected at 4°C within 60 min, transferred to a thermostatically controlled channel style perfusion chamber, and cannulated as previously described (16, 17) . The perfusion flow rate (V o) was maintained at 2.0 -4.0 nl/min (mean flow rate 2.61 Ϯ 0.04). The bath solution was exchanged at a constant flow rate of 1.0 ml/min and maintained at 37 Ϯ 2°C. The luminal perfusion solution contained 50 Ci of [methox-
3 H] inulin exhaustively dialyzed by the method of Shafer et al. (23) and 5 Ci 22 Na as NaCl. Bath collections were taken in tandem with perfusate collections to control for mechanical leak. Any collection with Ͼ5% leak was rejected. After an initial equilibration period of 30 min, period 1 samples of the effluent were collected into a constant volume pipette, which was transferred into a scintillation vial for counting. The luminal solution was then exchanged (mock during time control experiments), and a second 30-min equilibration phase followed before the period 2 collections. Unidirectional (lumen to bath) 22 Na flux (JNa, in pmol·mm Ϫ1 ·min Ϫ1 ) was calculated as previously reported (35) .
Chemicals. Radioisotopes were obtained from Perkin Elmer (Boston, MA). Benzamil hydrochloride, hydrochlorothiazide (HCTZ), ET-1, BQ-123, and BQ-788 were obtained from Sigma Chemical (St. Louis, MO). All other chemicals were obtained from Sigma Chemical or Fisher Scientific.
Statistical analyses. The results are expressed as means Ϯ SE. One-way or two-way ANOVA (with repeated measures for paired experiments) was used to compare J Na between groups. Differences between groups were considered statistically significant at P Ͻ 0.05.
RESULTS
Na reabsorption in the CCD is mediated by benzamilsensitive and -insensitive mechanisms.
Given the length of time required to ensure equilibration and perform multiple timed collections during each period, time control experiments were performed to determine whether Na reabsorption changed significantly over the duration of the experiment. Gender differences were also evaluated. The rate of Na reabsorption did not change significantly between period 1 and period 2 in either male or female mice ( Fig. 1) , and male and female mice exhibited similar rates of Na reabsorption.
To assess the activity of ENaC, experiments were performed where 1 M benzamil hydrochloride was present in the perfusate during period 2. The rate of Na reabsorption in both genders was significantly inhibited by benzamil (Fig. 2) . Benzamil inhibited Na reabsorption by 39 and 40% in female and males, respectfully. Previous studies have reported Na homeostasis changes during the menstrual cycle, and ENaC is regulated by estrogen and progesterone (5, 8, 11) . Chang et al. (5) reported that the female sex steroid hormones affect ENaC subunit mRNA expression, protein translation, and ENaC activity in renal collecting tubule cells, suggesting a role in premenstruation edema. In addition, Nakano and Pollock (19) reported that intramedullary infusion of ET-1 increased urinary Na excretion in female, but not male, sl/sl rats. In an effort to avoid female hormone modulation of ENaC, we performed our assessment of the contribution of ENaC in Na reabsorption and the regulation of this transport by ET-1 strictly in males.
To determine if the benzamil-insensitive transport was mediated by a HCTZ-sensitive mechanism, we measured the effect of HCTZ on Na reabsorption in the presence of benzamil (Fig. 3) . HCTZ did not significantly inhibit the residual Na reabsorption.
Na reabsorption in the OMCD is mediated entirely by ENaC. Na reabsorption was heterogeneous along the CD with greater rates in the CCD than in the OMCD. The rate of Na reabsorption in the OMCD was less than half that of the CCD [CCD 72.6 Ϯ 8.6 (n ϭ 6) vs. OMCD 33.1 Ϯ 5.5 (n ϭ 4)]. As shown in Fig. 4 , benzamil inhibited the majority of Na reabsorption in the OMCD from male mice.
ET-1 decreases Na reabsorption in the CCD. To date, the effect of ET-1 on Na transport has not been evaluated by directly measuring Na in the isolated, microperfused CCD but has been inferred from studies measuring Na-K-ATPase activity in primary cell culture (34), chloride and fluid absorption in the perfused CCD (29) , intracellular calcium response in rabbit and mouse CD (14, 20) , and Na channel activity in the CCD (2, 3). Our study confirms these previous reports that ET-1 inhibits Na reabsorption. In the presence of ET-1 (20 nM, luminal and basolateral), Na reabsorption was inhibited compared with the control experiments [CCD 72.6 Ϯ 8.6 (n ϭ 6) vs. 26.8 Ϯ 7.2 (n ϭ 6)]. To evaluate the activity of ENaC in the presence of ET-1, benzamil was added to the luminal perfusate during period 2. In the presence of ET-1, the effect of benzamil on Na reabsorption did not reach statistical significance (P ϭ 0.12; Fig. 5 ). There was a strong inhibitory effect of ET-1 on Na reabsorption in the presence and absence of benzamil (two-way repeated-measures ANOVA, P Ͻ 0.05). To determine if ET-1 affected the benzamil-insensitive component of Na reabsorption, we performed paired experiments (Fig. 6) . However, ET-1 had no effect on the Na reabsorption in the presence of benzamil.
ET A and ET B receptors mediate ET-1 action in the CCD.
To determine the ET-1 receptor(s) involved in mediating the ET-1 inhibitory effect on Na reabsorption, experiments were performed in the presence of ET-1 receptor inhibitors. We measured the effect of benzamil on Na reabsorption in the presence of ET-1 plus either the ET A receptor inhibitor BQ-123 (1 M, basolateral) or the ET B receptor inhibitor BQ-788 (1 M, basolateral; Fig. 7 ). Both ET-1 receptor inhibitors restored Na reabsorption to basal rates; however, only blockade of the ET A receptor appears to restore Na reabsorption that is benzamil sensitive.
DISCUSSION
We report that ET-1 inhibits a majority of Na reabsorption in the mouse CCD. This is the first study that directly measures the effect of ET-1 on Na reabsorption in the microperfused CCD. Our data support prior studies of the isolated, perfused rat CCD that reported an inhibitory effect of ET-1 on chloride and water reabsorption (29) . Our data strongly support that ET-1 downregulates Na reabsorption via ENaC. When ET-1 was present in the luminal and peritubular solutions, Na reabsorption was reduced by 63% compared with control, and the residual Na transport was Ͻ30 pmol·mm Ϫ1 ·min Ϫ1 . The residual Na transport was not statistically inhibited with luminal benzamil (P ϭ 0.12), suggesting that ENaC activity was small in the presence of ET-1. Direct evidence that ET-1 decreases ENaC activity has been previously reported ( The current findings suggest that both ET-1 receptors play a role in ET-1 regulation of Na reabsorption. In the absence of ET-1, benzamil inhibited less than half of the total Na flux confirming previous reports (discussed below) that a benzamilinsensitive transport mechanism exists in the CCD. It is unlikely that passive Na diffusion accounts for a significant portion of the residual (benzamil-insensitive) transport in our experiments because in the presence of ET-1 and benzamil, the rate of transport was Ͻ15 pmol·mm Ϫ1 ·min Ϫ1 . More importantly, benzamil fully inhibited Na transport in the OMCD to a value not significantly different from zero confirming that near zero rates can be accurately measured. The isotopic 22 Na flux rates reported herein are greater than the reported measurements of net Na flux in the mouse CCD, but these two measurements cannot be equated. When isotopic and net flux for Na are measured in the same tubule, isotopic flux significantly exceeds net Na flux (24) . The isotopic flux is similar with other observations for 22 Na efflux in the CCD of the rabbit (24) .
The emerging concept that B-type intercalated cells (ICs) can absorb NaCl and K extends our understanding of the role of different cell types in the CD in regulating blood pressure. These novel mechanisms are reviewed in Eladari et al. (7) . Several studies report that ENaC is not the only significant mechanism for Na reabsorption in the CD. Targeted deletion of the ␣-subunit of ENaC in the CD inhibited ENaC activity but did not impair Na balance (22) . This was interpreted as evidence of significant Na transport mechanisms in more proximal segments but may also indicate the significance of ENaCindependent transport mechanisms in the CD. More directly, two pharmacologically different Na transport mechanisms have been reported in the CCD (28, 30, 31) . These include the classic electrogenic, amiloride-sensitive Na transport mechanism mediated by ENaC and an electroneutral benzamil-insensitive, thiazide-sensitive mechanism. Recently, the second mechanism was described by Leviel et al. (15) as a coupling of pendrin-mediated Cl transport with the Na-dependent Cl/HCO 3 exchanger NDCBE/Slc4a8 for net reabsorption of NaCl by B-type ICs. In the present study, inhibition of either ET A or ET B receptor fully restored Na reabsorption to the basal rate. ET A blockade restored a benzamil-sensitive component of Na reabsorption presumably ENaC, whereas, ET B blockade restored a benzamil-insensitive Na reabsorptive mechanism. In a previous report, we investigated the frequency of functionally defined ICs in the mouse CCD and determined that B-type ICs comprise ϳ50% of the ICs in the middle portion of the CCD and Ͻ25% in the inner CCD (16) , which is consistent with ultrastructural and immunological studies (12, 27) . If B-type IC transporters are responsible for benzamil-insensitive Na transport, then the activity should be diminished in the medullary segments of the CD. Indeed, Na reabsorption in the OMCD was entirely benzamil-sensitive, suggesting that only ENaC is functioning in the OMCD where principal cells and A-type ICs far outnumber any B-type ICs.
To definitively determine whether ET-1 was downregulating Na reabsorption through an ENaC-independent mechanism, we performed paired experiments in which we measured the effect of HCTZ and ET-1 during ENaC-inhibition. Under the conditions of our experiments, we did not observe a HCTZ-sensitive component of Na reabsorption during ENaC-inhibition. Additionally, ET-1 had no effect on the ENaC-independent Na reabsorption. The present data suggest that ET-1 inhibits exclusively a benzamil-sensitive mechanism, presumably ENaC, under the conditions of these experiments, namely mice on a normal Na diet. However, these conclusions do not extend to mice fed a Na-restricted diet. Indeed, on a Na-restricted diet evidence suggests that a Na-driven Cl/HCO 3 exchanger (SLC4A8) and a Na-independent Cl/HCO 3 exchanger (SLC26A4) function to produce a component of CCD Na absorptive flux (15) . Moreover, in our studies when ET A was blocked, a benzamilsensitive component of Na transport was present and ET-1 binding to the ET B receptor failed to decrease Na reabsorption. Similarly, when ET B was blocked, ET-1 binding to ET A failed to reduce Na transport; however, Na reabsorption was entirely benzamil insensitive. Our data suggest that ET-1 reduces Na reabsorption via a pathway that is sensitive to ET A receptor binding that inhibits ENaC. Only when the ET B receptor is blocked did we see obliteration of ENaC activity, suggesting Na is then reabsorbed by an ENaC-independent mechanism. Previous single-channel studies have reported that either blockade or knockout of the ET B receptor, but not ET A receptor, inhibited or decreased the effects of ET-1 on ENaC activity (3). Furthermore, ET-1 decreased ENaC activity in WT and CD ET A KO mice but not in CD ET B KO and CD ET A/B KO mice strongly signifying that ET-1 inhibition of ENaC is mediated through the ET B receptor in the mouse CD (2) . The abrogation of the effect of benzamil on Na reabsorption in the presence of ET-1 plus the ET B blocker (Fig. 8) differs from these previous studies and suggests that the ET A receptor is responsible for the inhibition of ENaC by ET-1 under the conditions of these experiments. Aside from the difference in preparations, a plausible explanation of the difference in results include the experiment design. In the present experiments, the effect of BQ-123 and BQ-788 was examined in the presence of ET-1. In addition, benzamil was used to assess the contribution of ENaC.
However, in studies using the CD ET A/B KO, it has been reported that the ET A and ET B receptors exert a combined hypotensive effect that exceeds that of either receptor alone (9) . In our study, ET A blockade fully restored Na reabsorption to basal values and did not appear to affect the benzamil component of Na reabsorption. Thus ET-1 binding to the ET B receptor during ET A blockade does not inhibit ENaC. More importantly, our data imply that the ET A receptor is likely involved in ET-1-regulated, ENaC-mediated Na reabsorption.
In summary, the CD reabsorbs Na through ENaC in the OMCD and through ENaC-dependent and -independent mechanisms in the CCD. ET-1 regulation of Na reabsorption in the CCD involves both ET A and ET B receptors. Future studies should clarify the significance of these transport mechanisms in volume homeostasis and blood pressure control.
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